Antiestrogen-HDACi hybrid molecules for breast cancer treatment.
Antiestrogen-HDACi hybrid molecules for breast cancer treatment.
批准号:
260641
负责人:
Mader Sylvie N
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-03-01 至 2013-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is the most common form of cancer in women in the Western world. As growth of 2/3 of breast tumors can be stimulated by the hormone estrogen, compounds that block its action (antiestrogens, AEs) have been used in the clinic with considerable
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action of antiestrogens in breast cancer: roles of ubiquitin-like modifications in transcriptional inactivation of Estrogen Receptor alpha.
-
批准号:480045
-
项目类别:Operating Grants
-
资助金额:$61.3万
-
财政年份:2023
-
负责人:Mader Sylvie N
-
依托单位:
Mechanisms of action of antiestrogens in breast cancer: roles of Ubi-like modifications in transcriptional inactivation of Estrogen Receptor alpha.
-
批准号:472352
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Mader Sylvie N
-
依托单位:
Mechanisms of action of antiestrogens: towards improved treatment of relapse in ER+ breast cancer
-
批准号:372071
-
项目类别:Operating Grants
-
资助金额:$54.34万
-
财政年份:2017
-
负责人:Mader Sylvie N
-
依托单位:
Mechanisms controlling estrogen receptor alpha expression and activity in breast tumorigenesis
-
批准号:358549
-
项目类别:Operating Grants
-
资助金额:$66.32万
-
财政年份:2016
-
负责人:Mader Sylvie N
-
依托单位:
Mechanisms of action of full antiestrogens
-
批准号:268027
-
项目类别:Operating Grants
-
资助金额:$50.72万
-
财政年份:2012
-
负责人:Mader Sylvie N
-
依托单位:
海外基金